Laser Focus World is an industry bedrock—first published in 1965 and still going strong. We publish original articles about cutting-edge advances in lasers, optics, photonics, sensors, and quantum technologies, as well as test and measurement, and the shift currently underway to usher in the photonic integrated circuits, optical interconnects, and copackaged electronics and photonics to deliver the speed and efficiency essential for data centers of the future.

Our 80,000 qualified print subscribers—and 130,000 12-month engaged online audience—trust us to dive in and provide original journalism you won’t find elsewhere covering key emerging areas such as laser-driven inertial confinement fusion, lasers in space, integrated photonics, chipscale lasers, LiDAR, metasurfaces, high-energy laser weaponry, photonic crystals, and quantum computing/sensors/communications. We cover the innovations driving these markets.

Laser Focus World is part of Endeavor Business Media, a division of EndeavorB2B.

Laser Focus World Membership

Never miss any articles, videos, podcasts, or webinars by signing up for membership access to Laser Focus World online. You can manage your preferences all in one place—and provide our editorial team with your valued feedback.

Magazine Subscription

Can you subscribe to receive our print issue for free? Yes, you sure can!

Newsletter Subscription

Laser Focus World newsletter subscription is free to qualified professionals:

The Daily Beam

Showcases the newest content from Laser Focus World, including photonics- and optics-based applications, components, research, and trends. (Daily)

Product Watch

The latest in products within the photonics industry. (9x per year)

Bio & Life Sciences Product Watch

The latest in products within the biophotonics industry. (4x per year)

Laser Processing Product Watch

The latest in products within the laser processing industry. (3x per year)

Get Published!

If you’d like to write an article for us, reach out with a short pitch to Sally Cole Johnson: [email protected]. We love to hear from you.

Photonics Hot List

Laser Focus World produces a video newscast that gives a peek into what’s happening in the world of photonics.

Following the Photons: A Photonics Podcast

Following the Photons: A Photonics Podcast dives deep into the fascinating world of photonics. Our weekly episodes feature interviews and discussions with industry and research experts, providing valuable perspectives on the issues, technologies, and trends shaping the photonics community.

Editorial Advisory Board

  • Professor Andrea M. Armani, University of Southern California
  • Ruti Ben-Shlomi, Ph.D., LightSolver
  • James Butler, Ph.D., Hamamatsu
  • Natalie Fardian-Melamed, Ph.D., Columbia University
  • Justin Sigley, Ph.D., AmeriCOM
  • Professor Birgit Stiller, Max Planck Institute for the Science of Light, and Leibniz University of Hannover
  • Professor Stephen Sweeney, University of Glasgow
  • Mohan Wang, Ph.D., University of Oxford
  • Professor Xuchen Wang, Harbin Engineering University
  • Professor Stefan Witte, Delft University of Technology

Cancer Victims Support Sen. Richard Blumenthal in Urging Johnson & Johnson to Accept Responsibility

Senator cites bipartisan agreement on need for action

At a recent news conference, Sen. Richard Blumenthal, D-Conn., flanked by ovarian cancer victims Lynn Skoda and Joan Kiley, sharply criticized Johnson & Johnson (NYSE: JNJ) for its role in the spread of cancer through its talcum powder products.

Ms. Kiley conveyed her emotional story, holding a photograph of her loved ones taken during her chemotherapy for ovarian cancer. Her account emphasized the broad impact of Johnson & Johnson's alleged negligence, highlighting the collective suffering of many families.

Sen. Blumenthal attacked J&J’s evasive legal maneuvering, known as the "Texas Two-Step." He detailed how in October 2021 Johnson & Johnson moved its litigation liabilities from the talc lawsuits to a subsidiary called LTL Management without providing assets sufficient to address the basic economic damages of individual claimants.

Sen. Blumenthal spotlighted the bipartisan nature of the concern surrounding this issue. "The Judiciary Committee recently convened a hearing on this situation,” he said. “There was a clear bipartisan agreement on the urgency to address the matter. Both Republicans and Democrats recognize that this situation demands action, potentially in the form of new legislation. In the interim, companies like Johnson & Johnson should step forward and provide justice."

“From Main Street to Wall Street, it’s obvious the pendulum has swung against massively profitable corporations attempting to use bankruptcy to avoid responsibility for their defective products,” said attorney Andy Birchfield, head of the Mass Torts Section at the Beasley Allen Law Firm, who has led the fight on behalf of cancer victims to oppose J&J’s attempt to revictimize tens of thousands of women with ovarian cancer who are fighting for their lives. “We appreciate Sen. Blumenthal’s commitment to justice along with legislators from both parties who join us in saying ‘no’ to this kind of corporate abuse.”

Despite Johnson & Johnson's impressive revenue of more than $97 billion in 2022, the company has unsuccessfully sought bankruptcy to force claimants to accept a proposed settlement of $8.9 billion, an amount grossly insufficient to cover even basic medical expenses for victims and their families. Reportedly, the company is considering filing for bankruptcy a third time, after courts dismissed its first two bankruptcy filings ruling, they were made in bad faith.

At the news conference, the senator expressed admiration for Ms. Skoda and Ms. Kiley, noting that their cancers are believed to be linked to talcum powder distributed by Johnson & Johnson. Sen. Blumenthal emphasized that Johnson’s Baby Powder, which independent testing showed contains asbestos, has been associated with the suffering of tens of thousands of women, due in part to the company's failure to issue sufficient warnings.

Ms. Skoda recounted her own battle with stage three ovarian cancer beginning in 2017, detailing the extensive medical procedures that often accompany treatment. Later, DNA testing showed she had no genetic predisposition to ovarian cancer, suggesting her exposure to talcum powder as an infant may be the cause of her illness.

“Sen. Blumenthal is part of a growing chorus of concerned lawmakers challenging Johnson & Johnson to rise to the occasion,” said Mr. Birchfield. “We believe it’s essential that our leaders reinforce that J&J has a moral and legal obligation to address the harm caused by the company’s talcum powder products.”

For the complete press conference, watch the video.

Contacts

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.